Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need


32nd Annual Piper Sandler Healthcare Conference
 November 23, 2020 -
December 3, 2020

Cardiff Oncology CEO, Dr. Mark Erlander, will participate in a fireside chat and 1x1 meetings with investors during the 32nd Annual Piper Sandler Healthcare Conference on December 1st - 3rd, 2020. Beginning November 23rd, a pre-recorded fireside chat with company management will be available for viewing anytime through December 3rd by accessing the recording library on the Piper Sandler conference site.